In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.
Fenton’s Valarie De La Garza On LatinX Leadership
Keeping Earned Media’s Seat At The Table
What Comms Pros Need To Know About Climate Lobbying
The Change Agencies On Inclusive Communications
Navigating and Leading Through The Heavy Impact of Trauma
Niche Practices Translate To Big Learnings For The Greater Agency
PR in Ukraine, one year after the invasion
CommsIndex with Sylvia Evans and Charles Lankester
Igniting the Industry: Making Change With Purpose
The Agency Within The Agency: Bringing Creative In-House
More Than Medicine: Is Corporate Reputation The New Gold Standard?
Setting Course for Women-Led Entrepreneurship in PR
The Importance Of Indigenous Perspectives
AJ Jones On Starbucks, DEI & Employee Partners
Why Consumer Empowerment Is Leading To A Boom In Asia-Pacific Health Care Communications
Building Coalitions That Command Lasting Change
Davos Voices: Abhinav Kumar, Brian Lott, Jill Kouri
Engaging Regional Expertise To Differentiate When Launching In Latin America
Chasing Profit In A Changing Media Landscape
Growth Out Of Global: Summit Trends To Watch For in 2023
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money